World's Best Scientists 2026 revealed!
Critical Reviews in Oncology/Hematology
H-index 41

Critical Reviews in Oncology/Hematology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 401 250 313 39

Additional Metrics

Number of Best Scientists*: 351
Documents by Best Scientists*: 379
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 153
SCIMAGO SJR: 1.82
Impact Factor: 5.6

Overview

Top Research Topics at Critical Reviews in Oncology Hematology?

The journal generally zeroes in on subjects such as Internal medicine, Oncology, Cancer, Chemotherapy and Surgery. The Internal medicine research presented places emphasis on topics like Breast cancer, Clinical trial, Radiation therapy, Disease and Meta-analysis. Topics in Oncology were tackled in line with various other fields like Colorectal cancer, Randomized controlled trial, Prostate cancer and Immunotherapy.

Critical Reviews in Oncology Hematology facilitates discussions on Cancer that incorporate concepts from other fields like Pathology, Cancer research, MEDLINE and Intensive care medicine. Carcinogenesis and Immunology are some topics wherein Cancer research research discussed in Critical Reviews in Oncology Hematology have an impact. The main emphasis of Critical Reviews in Oncology Hematology is the subject of Immunology, focusing on Immune system.

  • Internal medicine (43.95%)
  • Oncology (34.87%)
  • Cancer (27.34%)

What are the most cited papers published in the journal?

  • Epidermal growth factor-related peptides and their receptors in human malignancies (2441 citations)
  • Pathological prognostic factors in breast cancer. (1619 citations)
  • The cellular and molecular basis of hyperthermia. (1213 citations)

Research areas of the most cited articles at Critical Reviews in Oncology Hematology:

The published papers focus largely on the fields of Cancer, Internal medicine, Cancer research, Immunology and Oncology. The journal publications explore research in Cancer alongside concepts in Clinical trial and other areas of study in Pharmacology. The most cited articles focus on Internal medicine but the discussions also offer insight into other areas such as Endocrinology and Surgery.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

Critical Reviews in Oncology Hematology explores disciplines such as Internal medicine, Oncology, Cancer, Meta-analysis and Cancer research. In the Internal medicine research discussed, Clinical trial, Chemotherapy, Adverse effect, Randomized controlled trial and Radiation therapy are all tackled. The journal aims to form a more comprehensive understanding of the field by integrating disciplines like Radiation therapy and In patient.

While work presented in it provided substantial information on Oncology, it also covered topics in Disease, Hazard ratio, Breast cancer, Colorectal cancer and Immunotherapy. The journal holds forums on Cancer that merges themes from other disciplines such as Incidence (epidemiology) and Intensive care medicine. The work on Cancer research tackled in it brings together disciplines like Targeted therapy and Metastasis.

The most cited articles from the last journal are:

  • Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. (24 citations)
  • Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. (19 citations)
  • Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives. (18 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Critical Reviews in Oncology Hematology (based on the number of publications) are:

  • Matti Aapro (30 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Silvio Monfardini (29 papers) absent at the last edition,
  • Daniele Santini (25 papers) absent at the last edition,
  • Christian Rolfo (23 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Antonio Russo (23 papers) published 5 papers at the last edition, 4 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Critical Reviews in Oncology Hematology (based on the number of publications) are:

  • Sapienza University of Rome (93 papers) published 9 papers at the last edition, 7 more than at the previous edition,
  • European Institute of Oncology (90 papers) published 12 papers at the last edition, 2 more than at the previous edition,
  • University of Milan (64 papers) published 8 papers at the last edition, 1 more than at the previous edition,
  • University of Turin (62 papers) published 12 papers at the last edition, 3 more than at the previous edition,
  • Harvard University (56 papers) published 9 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 12.30% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.62% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.60% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.31% of all publications and 57.47% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Continuing Education Opportunities

It's important to note that ongoing education is an essential aspect of any professional thriving in the Oncology or Hematology specialty. Even though this article provides a comprehensive review of the research topics in the critical reviews in Oncology Hematology, professionals working in this field may need additional, more practical knowledge. This could be gained by enrolling in related programs or courses. For instance, professionals willing to broaden their understanding of patient care can consider LPN (Licensed Practical Nurse) programs. This would not only deepen their understanding of diseases but could also give them a wider perspective on Oncology care. For those situated in North Dakota or looking for online options, you can check out the lpn programs in North Dakota online. Engaging in additional professional development can only enhance the quality of care provided to Oncology patients and further enrich contributions to research in this field. The new insights gained from further studies can inspire future research topics revolving around cutting-edge treatment strategies and advancements in patient care. It's a worthy investment towards the progress in Oncology and Hematology research.

Top Publications

  • Unmet supportive care needs of people with advanced cancer and their caregivers: a systematic scoping review.

    (2022)
    173 Citations
  • Lung cancer in never smokers: The role of different risk factors other than tobacco smoking.

    Luis Corrales;Rafael Rosell;Andrés F. Cardona;Claudio Martín

    (2020)
    162 Citations
  • Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.

    Parisa Naeli;Mohammad Hossein Pourhanifeh;Mohammad Reza Karimzadeh;Zahra Shabaninejad;Zahra Shabaninejad

    (2020)
    141 Citations
  • Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma.

    Giuseppe Lamberti;Elisa Andrini;Monia Sisi;Alessandro Rizzo

    (2020)
    116 Citations
  • Major and minor salivary gland tumours.

    (2020)
    111 Citations
  • Liquid biopsy in bladder cancer: state of the art and future perspectives.

    (2022)
    109 Citations
  • Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.

    Zahra Sadat Razavi;Vida Tajiknia;Shahab Majidi;Maryam Ghandali

    (2021)
    98 Citations
  • Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

    Christian Rolfo;Andrés F Cardona;Massimo Cristofanilli;Luis Paz-Ares

    (2020)
    88 Citations
  • Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies.

    Nathalie Michels;Carola van Aart;Jens Morisse;Amy Mullee

    (2021)
    85 Citations
  • New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

    Elie Rassy;Elie Rassy;Pauline Parent;Felix Lefort;Stergios Boussios

    (2020)
    78 Citations

Related Online Degrees & Career Pathways

For those exploring options beyond traditional medical degrees, several online programs offer flexible and accessible pathways into the healthcare field. Programs like the online dnp provide a convenient route for nurses aiming to advance their clinical expertise without compromising work and personal commitments.

If you're interested in the administrative side of healthcare, pursuing an online healthcare administration degree can open doors to leadership roles in hospitals and clinics. Such programs focus on management skills crucial to the smooth operation of healthcare facilities.

For those seeking quicker entry into the healthcare workforce, exploring options like the medical billing and coding course can be a smart choice. These courses teach essential skills for handling medical records and insurance claims, a vital function in healthcare.

Additionally, students considering nursing might find value in programs offered by easy nursing colleges to get into. These schools often provide simpler admission processes, making the nursing profession more accessible while still delivering quality education.

Best Scientists Contributing to This Journal

Recently Published Articles